We are live on ! Find out more
PP

Pacifica Partners Portfolio holdings

AUM $332M
1-Year Est. Return 59.28%
This Fund
S&P 500
This Quarter Est. Return
+4.11%
1 Year Est. Return
+59.28%
3 Year Est. Return
+122.71%
5 Year Est. Return
+144.58%
10 Year Est. Return
AUM
$154M
AUM Growth
+$709K
Cap. Flow
+$2.55M
Cap. Flow %
1.66%
Top 10 Hldgs %
34.2%
Holding
509
New
19
Increased
77
Reduced
59
Closed
14

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$3.64M
2
C icon
Citigroup
C
+$1.48M
3
STZ icon
Constellation Brands
STZ
+$402K
4
VLO icon
Valero Energy
VLO
+$385K
5
BMY icon
Bristol-Myers Squibb
BMY
+$251K

Sector Composition

Rank Sector Weight
1 Financials 17.71%
2 Technology 17.1%
3 Energy 14.76%
4 Communication Services 8.83%
5 Materials 7.19%

Similar funds

Pacifica Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Pacifica Partners held 509 positions worth $154M, up 0.46% from $153M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pacifica Partners's Q1 2022 filing shows 19 new, 77 increased, 59 reduced and 14 closed positions. Its largest new stake was Accenture: 375 shares worth $119K. The largest sale was CVS Health, an estimated $3.64M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Energy.

  • Pacifica Partners's largest Q1 2022 buy was Accenture: 375 shares worth $119K.
  • Pacifica Partners added most to Starbucks in Q1 2022, an estimated $1.76M increase.
  • Pacifica Partners's biggest Q1 2022 reduction was Citigroup, cutting an estimated $1.48M.
  • Pacifica Partners fully exited CVS Health in Q1 2022, selling an estimated $3.64M.
  • Pacifica Partners's ten largest holdings make up 34% of its $154M portfolio in Q1 2022.
  • Pacifica Partners opened 19 new positions and closed 14 in Q1 2022.
  • Pacifica Partners's portfolio value rose 0.46% quarter-over-quarter to $154M.

Based on Pacifica Partners's 13F filing for Q1 2022, filed 12 Apr 2022.